Scarica l'app Stockscreener
58.50
0.27%
-0.16
Dopo l'orario di chiusura:
58.49
-0.010
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$58.66
Aprire:
$59.16
Volume 24 ore:
1.14M
Relative Volume:
0.48
Capitalizzazione di mercato:
$9.15B
Reddito:
$1.22B
Utile/perdita netta:
$81.07M
Rapporto P/E:
113.79
EPS:
0.5141
Flusso di cassa netto:
$223.02M
1 W Prestazione:
+5.96%
1M Prestazione:
+15.04%
6M Prestazione:
-1.81%
1 anno Prestazione:
+14.55%
Intervallo 1D:
$58.09
$59.78
Intervallo di 1 settimana:
$53.44
$60.44
Portata 52W:
$46.01
$72.16
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
612-379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
58.50 | 9.18B | 1.22B | 81.07M | 223.02M | 0.5141 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.85 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corp (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sumitomo Mitsui Trust Group Boosts Stake in Bio-Techne - National Today
Massachusetts Financial Services Co. MA Has $235.99 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Q1 2026 Bio-Techne Corp Earnings Call Transcript - GuruFocus
Traders Bet Big on Bio-Techne Decline with Put Options Surge - National Today
Traders Purchase High Volume of Put Options on Bio-Techne (NASDAQ:TECH) - MarketBeat
Rep. April McClain Delaney Sells Bio-Techne Corp Stock - National Today
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Stock - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
April McClain Delaney makes multiple trades in Bio-Techne, BJ’s Wholesale, and Nasdaq - Investing.com
Sivik Global Healthcare LLC Takes $2.65 Million Position in Bio-Techne Corp $TECH - MarketBeat
Precision Trading with Bio-techne Corp (TECH) Risk Zones - Stock Traders Daily
Bio-Techne (TECH) SVP exercises 2,259 RSUs, 740 shares withheld - Stock Titan
How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story - simplywall.st
FOMO Trade: How much upside does Bio Techne Corporation haveWeekly Market Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Bio-Techne (TECH) Stock Sees Analyst Price Target Downgrade | TECH Stock News - GuruFocus
Tudor Investment Corp Acquires $13.5M Stake in Bio-Techne - National Today
242,016 Shares in Bio-Techne Corp $TECH Acquired by Tudor Investment Corp ET AL - MarketBeat
TECH Should I Buy - Intellectia AI
Bio-Techne Corporation (TECH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com
Bio-Techne Corp (1TECH.MI) Analyst Insights, Price Targets & Recommendations - ca.finance.yahoo.com
Assessing Bio-Techne (TECH) Valuation After COMET Spatial Biology Platform Expansion - Yahoo Finance
TECH Stock Price, Quote & Chart | BIO-TECHNE CORP (NASDAQ:TECH) - ChartMill
SG Americas Securities LLC Acquires 126,702 Shares of Bio-Techne Corp $TECH - MarketBeat
ETF Watch: What are the future prospects of Bio Techne Corporation2026 Catalysts & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Small-MidCap Dividend Income Fund's Bio-Techne Corp(TECH) Holding History - GuruFocus
SPYRE Focus Panel launch fails to lift Bio-Techne stock amid pronounced bearish momentum - Traders Union
Fort Washington Investment Advisors Reduces Stake in Bio-Techne - National Today
Fort Washington Investment Advisors Inc. OH Sells 146,767 Shares of Bio-Techne Corp $TECH - MarketBeat
Technical Reactions to TECH Trends in Macro Strategies - Stock Traders Daily
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Riverbridge Partners LLC Has $46.21 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Vanguard disaggregates holdings, reports 0% in Bio‑Techne (NASDAQ: TECH) - Stock Titan
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks - Yahoo Finance
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal
Bio-Techne expands spatial biology product portfolio - Investing.com
Bio-Techne expands spatial biology product portfolio By Investing.com - Investing.com UK
Bio-Techne adds tools aimed at harder-to-detect tissue targets - Stock Titan
Bio-Techne Sees Unusually Large Options Volume (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp. stock rises Monday, still underperforms market - MarketWatch
Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat
JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today
JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat
38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat
After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Barchart.com
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Techne Corp Azioni (TECH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
Feb 17 '26 |
Sale |
59.10 |
1,976 |
116,791 |
200 |
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):